NR Nicotinamide Riboside — Supplements
NAD+ precursor vitamin with demonstrated safety and efficacy for boosting cellular NAD+ levels.
Overview
Nicotinamide riboside (NR) is a form of vitamin B3 that serves as a precursor to NAD+ via the nicotinamide riboside kinase (NRK) pathway. NR is the most extensively studied oral NAD+ precursor in human clinical trials, with the NICE trial demonstrating functional improvement in peripheral artery disease patients. Multiple RCTs confirm that NR (250-1,000 mg/day) safely and significantly raises blood NAD+ levels. NR has FDA GRAS and NDI status, distinguishing it from NMN in regulatory clarity.
Indications
- NAD+ repletion and cellular energy support
- Cardiovascular health and vascular function
- Healthy aging and longevity
- Metabolic health optimization
Mechanism of Action
NR is phosphorylated by nicotinamide riboside kinase (NRK1/2) to form NMN
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Nicotinamide Riboside | 300 mg | Once daily (morning) | Take in the AM; 250-1,000 mg studied in clinical trials |
Evidence Grade
GRADE B
Safety & Contraindications
- Well-tolerated in clinical trials up to 2,000 mg/day
- Mild GI symptoms (nausea, bloating) reported at higher doses
- No significant adverse effects in multiple Phase I/II trials
- GRAS status provides higher regulatory confidence than some alternatives